Literature DB >> 20388800

Oncogenic role of miR-483-3p at the IGF2/483 locus.

Angelo Veronese1, Laura Lupini, Jessica Consiglio, Rosa Visone, Manuela Ferracin, Francesca Fornari, Nicola Zanesi, Hansjuerg Alder, Gemma D'Elia, Laura Gramantieri, Luigi Bolondi, Giovanni Lanza, Patrizia Querzoli, Adriano Angioni, Carlo M Croce, Massimo Negrini.   

Abstract

hsa-mir-483 is located within intron 2 of the IGF2 locus. We found that the mature microRNA (miRNA) miR-483-3p is overexpressed in 100% of Wilms' tumors. In addition, colon, breast, and liver cancers exhibit high or even extremely high levels of miR-483-3p in approximately 30% of the cases. A coregulation with IGF2 mRNA was detected, although some tumors exhibited high expression of miR-483-3p without a concomitant increase of IGF2. These findings suggested that miR-483-3p could cooperate with IGF2 or act as an autonomous oncogene. Indeed, here we prove that an anti-miRNA oligonucleotide against miR-483-3p could inhibit the miRNAs without affecting IGF2 mRNA and it could suppress tumorigenicity of HepG2 cells, a cell line that overexpresses miR-483-3p and IGF2. Conversely, no antitumor effect was elicited by inhibition of IGF2. The oncogenic mechanism of miR-483-3p was at least partially clarified by the finding that it could modulate the proapoptotic protein BBC3/PUMA and miR-483-3p enforced expression could protect cells from apoptosis. Our results indicate that miR-483-3p could function as an antiapoptotic oncogene in various human cancers and reveal a new, potentially important target for anticancer therapy. (c) 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388800      PMCID: PMC4303586          DOI: 10.1158/0008-5472.CAN-09-4456

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  PUMA, a novel proapoptotic gene, is induced by p53.

Authors:  K Nakano; K H Vousden
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

2.  Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.

Authors:  F L Sun; W L Dean; G Kelsey; N D Allen; W Reik
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

3.  Gain of imprinting of SLC22A18 sense and antisense transcripts in human breast cancer.

Authors:  E Gallagher; A Mc Goldrick; W Y Chung; O Mc Cormack; M Harrison; M Kerin; P A Dervan; A Mc Cann
Journal:  Genomics       Date:  2006-04-19       Impact factor: 5.736

4.  Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.

Authors:  A Weston; J C Willey; R Modali; H Sugimura; E M McDowell; J Resau; B Light; A Haugen; D L Mann; B F Trump
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Antisense oligodeoxynucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II.

Authors:  S B Lin; S H Hsieh; H L Hsu; M Y Lai; L S Kan; L C Au
Journal:  J Biochem       Date:  1997-10       Impact factor: 3.387

6.  Loss of methylation at chromosome 11p15.5 is common in human adult tumors.

Authors:  Rosaria A M Scelfo; Christine Schwienbacher; Angelo Veronese; Laura Gramantieri; Luigi Bolondi; Patrizia Querzoli; Italo Nenci; George A Calin; Adriano Angioni; Giuseppe Barbanti-Brodano; Massimo Negrini
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

7.  Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.

Authors:  Ayumi Satoh; Minoru Toyota; Hideyuki Ikeda; Yoshikazu Morimoto; Kimishige Akino; Hiroaki Mita; Hiromu Suzuki; Yasushi Sasaki; Takayuki Kanaseki; Yukio Takamura; Hidenobu Soejima; Takeshi Urano; Kazuyoshi Yanagihara; Takao Endo; Yuji Hinoda; Masahiro Fujita; Masao Hosokawa; Noriyuki Sato; Takashi Tokino; Kohzoh Imai
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

8.  Relaxation of imprinted genes in human cancer.

Authors:  S Rainier; L A Johnson; C J Dobry; A J Ping; P E Grundy; A P Feinberg
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

9.  MicroRNAs in human cancer: from research to therapy.

Authors:  Massimo Negrini; Manuela Ferracin; Silvia Sabbioni; Carlo M Croce
Journal:  J Cell Sci       Date:  2007-06-01       Impact factor: 5.285

10.  Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour.

Authors:  Angela Sparago; Silvia Russo; Flavia Cerrato; Serena Ferraiuolo; Pierangela Castorina; Angelo Selicorni; Christine Schwienbacher; Massimo Negrini; Giovanni Battista Ferrero; Margherita Cirillo Silengo; Cecilia Anichini; Lidia Larizza; Andrea Riccio
Journal:  Hum Mol Genet       Date:  2006-12-11       Impact factor: 6.150

View more
  94 in total

1.  A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA.

Authors:  Sophie C Cazanave; Justin L Mott; Nafisa A Elmi; Steven F Bronk; Howard C Masuoka; Michael R Charlton; Gregory J Gores
Journal:  J Lipid Res       Date:  2011-06-01       Impact factor: 5.922

2.  Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma.

Authors:  Yi Zhou; Liu Hong
Journal:  Genet Test Mol Biomarkers       Date:  2013-05-13

3.  Gene networks in basal cell carcinoma of the eyelid, analyzed using gene expression profiling.

Authors:  Tatsuya Yunoki; Yoshiaki Tabuchi; Tetsushi Hirano; Shigeharu Miwa; Johji Imura; Atsushi Hayashi
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

4.  Integrated microRNA and mRNA responses to acute human left ventricular ischemia.

Authors:  Louis A Saddic; Tzuu-Wang Chang; Martin I Sigurdsson; Mahyar Heydarpour; Benjamin A Raby; Stanton K Shernan; Sary F Aranki; Simon C Body; Jochen D Muehlschlegel
Journal:  Physiol Genomics       Date:  2015-07-14       Impact factor: 3.107

5.  Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker.

Authors:  Jing Shen; Antai Wang; Qiao Wang; Irina Gurvich; Abby B Siegel; Helen Remotti; Regina M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-14       Impact factor: 4.254

6.  Mutated beta-catenin evades a microRNA-dependent regulatory loop.

Authors:  Angelo Veronese; Rosa Visone; Jessica Consiglio; Mario Acunzo; Laura Lupini; Taewan Kim; Manuela Ferracin; Francesca Lovat; Elena Miotto; Veronica Balatti; Lucilla D'Abundo; Laura Gramantieri; Luigi Bolondi; Yuri Pekarsky; Danilo Perrotti; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

Review 7.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Authors:  Kirti Bhatt; Qing-Sheng Mi; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

Review 8.  Minireview: miRomics in endocrinology: a novel approach for modeling endocrine diseases.

Authors:  Péter M Szabó; Henriett Butz; Péter Igaz; Károly Rácz; László Hunyady; Attila Patócs
Journal:  Mol Endocrinol       Date:  2013-01-24

Review 9.  Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma.

Authors:  Hend Mohamed El Tayebi; Ahmed Ihab Abdelaziz
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 10.  Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.

Authors:  H Wang; L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.